- Home
- PPBT vs GBR Comparison
PPBT vs GBR Comparison
Compare PPBT & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- GBR
- Stock Information
- Founded
- PPBT 2010
- GBR 1978
- Country
- PPBT Israel
- GBR United States
- Employees
- PPBT N/A
- GBR N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- GBR Oil & Gas Production
- Sector
- PPBT Health Care
- GBR Energy
- Exchange
- PPBT Nasdaq
- GBR Nasdaq
- Market Cap
- PPBT 6.2M
- GBR 7.0M
- IPO Year
- PPBT N/A
- GBR N/A
- Fundamental
- Price
- PPBT $2.08
- GBR $0.95
- Analyst Decision
- PPBT Strong Buy
- GBR
- Analyst Count
- PPBT 1
- GBR 0
- Target Price
- PPBT $33.00
- GBR N/A
- AVG Volume (30 Days)
- PPBT 258.8K
- GBR 26.7K
- Earning Date
- PPBT 08-15-2025
- GBR 08-12-2025
- Dividend Yield
- PPBT N/A
- GBR N/A
- EPS Growth
- PPBT N/A
- GBR N/A
- EPS
- PPBT N/A
- GBR N/A
- Revenue
- PPBT N/A
- GBR $148,000.00
- Revenue This Year
- PPBT N/A
- GBR N/A
- Revenue Next Year
- PPBT N/A
- GBR N/A
- P/E Ratio
- PPBT N/A
- GBR N/A
- Revenue Growth
- PPBT N/A
- GBR 3.50
- 52 Week Low
- PPBT $2.00
- GBR $0.67
- 52 Week High
- PPBT $13.95
- GBR $1.78
- Technical
- Relative Strength Index (RSI)
- PPBT 32.49
- GBR 41.50
- Support Level
- PPBT $2.35
- GBR $0.92
- Resistance Level
- PPBT $2.90
- GBR $1.05
- Average True Range (ATR)
- PPBT 0.17
- GBR 0.06
- MACD
- PPBT -0.06
- GBR -0.01
- Stochastic Oscillator
- PPBT 1.20
- GBR 14.74
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.